The biotechnology company reported $3.89 EPS for the quarter, beating the consensus estimate of $3.59 by $0.30. The business had revenue of $464.70 million for the quarter, compared to the consensus estimate of $420.55 million. United Therapeutics had a net margin of 24.22% and a return on …
0 Comments